These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 39039470)
1. Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine. Sun X; Chen B; Qi Y; Wei M; Chen W; Wu X; Wang Q; Li J; Lei X; Luo G J Headache Pain; 2024 Jul; 25(1):117. PubMed ID: 39039470 [TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease. Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492 [TBL] [Abstract][Full Text] [Related]
3. Genetic analysis from multiple cohorts implies causality between 2200 druggable genes, telomere length, and leukemia. Yun Z; Liu Z; Shen Y; Sun Z; Zhao H; Du X; Lv L; Zhang Y; Hou L Comput Biol Med; 2024 Oct; 181():109064. PubMed ID: 39216403 [TBL] [Abstract][Full Text] [Related]
4. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis. Lin J; Zhou J; Xu Y Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689 [TBL] [Abstract][Full Text] [Related]
5. Identification of drug targets for Sjögren's syndrome: multi-omics Mendelian randomization and colocalization analyses. Bai Y; Wang J; Feng X; Xie L; Qin S; Ma G; Zhang F Front Immunol; 2024; 15():1419363. PubMed ID: 38933282 [TBL] [Abstract][Full Text] [Related]
6. Identification of genetic association between mitochondrial dysfunction and knee osteoarthritis through integrating multi-omics: a summary data-based Mendelian randomization study. Xie J; Ma R; Xu X; Yang M; Yu H; Wan X; Xu K; Guo J; Xu P Clin Rheumatol; 2024 Nov; 43(11):3487-3496. PubMed ID: 39259428 [TBL] [Abstract][Full Text] [Related]
7. PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses. Han QJ; Zhu YP; Sun J; Ding XY; Wang X; Zhang QZ Front Pharmacol; 2024; 15():1418560. PubMed ID: 39035989 [TBL] [Abstract][Full Text] [Related]
8. Integrative multi-omics summary-based mendelian randomization identifies key oxidative stress-related genes as therapeutic targets for atrial fibrillation and flutter. Chen S; Sun J; Wen W; Chen Z; Yu Z Front Genet; 2024; 15():1447872. PubMed ID: 39359474 [TBL] [Abstract][Full Text] [Related]
9. Proteome-wide Mendelian randomization identified potential drug targets for migraine. Xiong Z; Zhao L; Mei Y; Qiu D; Li X; Zhang P; Zhang M; Cao J; Wang Y J Headache Pain; 2024 Sep; 25(1):148. PubMed ID: 39261750 [TBL] [Abstract][Full Text] [Related]
10. Identifying novel proteins for migraine by integrating proteomes from blood and CSF with genome-wide association data. Niu PP; Zhang R; Zhang C; Li S; Li YS CNS Neurosci Ther; 2024 Jun; 30(6):e14817. PubMed ID: 38898596 [TBL] [Abstract][Full Text] [Related]
11. Mendelian Randomization Using the Druggable Genome Reveals Genetically Supported Drug Targets for Psychiatric Disorders. Li X; Shen A; Zhao Y; Xia J Schizophr Bull; 2023 Sep; 49(5):1305-1315. PubMed ID: 37418754 [TBL] [Abstract][Full Text] [Related]
12. Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization. Zhang C; He Y; Liu L J Headache Pain; 2024 Jun; 25(1):100. PubMed ID: 38867170 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction and onset of type 2 diabetes along with its complications: a multi-omics Mendelian randomization and colocalization study. Li Y; Miao Y; Feng Q; Zhu W; Chen Y; Kang Q; Wang Z; Lu F; Zhang Q Front Endocrinol (Lausanne); 2024; 15():1401531. PubMed ID: 39280009 [TBL] [Abstract][Full Text] [Related]
14. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia. Yin KF; Chen T; Gu XJ; Su WM; Jiang Z; Lu SJ; Cao B; Chi LY; Gao X; Chen YP J Cachexia Sarcopenia Muscle; 2024 Aug; 15(4):1324-1334. PubMed ID: 38644354 [TBL] [Abstract][Full Text] [Related]
15. Exploration of protein and genetic targets causing atrioventricular block: mendelian-randomization analyses based on eQTL data and pQTL data. Wang T; Ma P; Wang X; Xia Y BMC Cardiovasc Disord; 2024 Oct; 24(1):528. PubMed ID: 39354406 [TBL] [Abstract][Full Text] [Related]
16. Identifying novel potential drug targets for endometriosis via plasma proteome screening. Tao T; Mo X; Zhao L Front Endocrinol (Lausanne); 2024; 15():1416978. PubMed ID: 39036049 [TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study. Qu K; Li MX; Yu P; ; Wu BH; Shi M; Dong M Sci Rep; 2024 May; 14(1):12094. PubMed ID: 38802400 [TBL] [Abstract][Full Text] [Related]
18. Exploration of potential novel drug targets for diabetic retinopathy by plasma proteome screening. Yuan W; Xu W; Xu X; Qu B; Zhao F Sci Rep; 2024 May; 14(1):11726. PubMed ID: 38778174 [TBL] [Abstract][Full Text] [Related]
19. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer. Song W; Li Y; Yao Y; Sun S; Guan X; Wang B BMC Cancer; 2024 Jun; 24(1):680. PubMed ID: 38834983 [TBL] [Abstract][Full Text] [Related]
20. Genetic causal relationship between immune diseases and migraine: a Mendelian randomization study. Li G; Duan S; ; Zheng T; Zhu T; Qu B; Liu L; Liu Z Front Immunol; 2024; 15():1376698. PubMed ID: 38650934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]